N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

54808-91-2

C20H25N3O2

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

MLS000756415;N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;Basofortina;Methergen;Partergin;Ergometrine, methyl-;Isomethergine;ME 277;D-Lysergic acid-(+)-butanolamide-(2);Methergin (Salt/Mix);Lysergamide, N-[(S)-1-(hydroxymethyl)propyl]-;Methergine (Salt/Mix);CHEMBL1597692;SCHEMBL16092804;BDBM86237;CHEBI:91798;DTXSID10859203;HMS2231B08;HMS3369A11;CAS_8226;NSC_8226;NSC186067;MCULE-8879242487;NSC-186067;SMR000528720;N-[.alpha.-(Hydroxymethyl)propyl]-D-lysergamide;L000928;BRD-A63667919-103-01-9;Q27163599;9,10-Didehydro-N-(.alpha.-(hydroxymethyl)propyl)-6-methyl-ergoline-8-.beta.-carboxamide;9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8.beta.-carboxamide;Ergoline-8.beta.-carboxamide, 9,10-didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methyl-;4,6,6a,7,8,9-Hexahydro-9-[1-(hydroxymethyl)propylcarbamoyl]-7-methylindolo[4,3-fg]quinoline;54808-91-2;Ergoline-8-carboxamide, 9,10-didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-, (8.beta.)-;Ergoline-8-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-6-methyl-, [8.beta.(S)]-;N-[1-(Hydroxymethyl)propyl]-6-methyl-9,10-didehydroergoline-8-carboxamide, [8.beta.(S)]- #